Biomarker Validation
Featured Protocols
Cancer Biomarkers
.
Vendor-submitted protocol
.
Sponsored by
Origene Technologies
.
Published in
November
2007
Latest Protocols
Vendor-submitted protocol.
Sponsored by
PerkinElmer
Published in
November
2009
The AlphaLISA® homogenous (i.e., no-wash) immunoassay platform employs a very simple assay protocol that is much faster than a traditional ELISA assay. When compared to competing TR-FRET homogeneous assays, AlphaLISA biomarker assays provide superior performance in terms of sensitivity, dynamic range, and variability.
Cancer Biomarkers
Vendor-submitted protocol.
Sponsored by
Origene Technologies
Published in
BioTechniques Protocol Guide 2009
TissueScan is a unique qPCR array for fast and accurate gene expression profiling across a large number of cancer patient samples. High-quality cDNAs were prepared from thousands of well-documented cancer biopsy samples, normalized, and assembled into ready-to-use gene expression panels.
Cancer Biomarkers
Vendor-submitted protocol.
Sponsored by
Origene Technologies
Published in
November
2007
TissueScan is a unique qPCR array of first-strand cDNA from hundreds of clinical tumor samples. It provides a fast and accurate gene expression profiling across a large number of cancer patient samples.
Cancer Biomarkers
Vendor-submitted protocol.
Published in
December 2006
2007
TissueScan is a unique RT-PCR based system for fast and accurate gene expression profiling across a large number of cancer patient samples. High-quality cDNAs were prepared from 48 well-documented cancer biopsy samples, normalized and assembled into ready-to-use gene expression panels.
